During the peritumoral treatment of K7 osteosarcoma-bearing BALB/c mice, the CA4/PTX co-loaded hydrogel exhibited significantly higher antitumor efficacy compared with free CA4/PTX mixed solution and the hydrogel loaded with CA4 or DTX-encapsulating microspheres. This evidence concerns the gene CA4 and osteosarcoma.